Benzinga's Top Downgrades
Analysts at Jefferies downgraded ONYX Pharmaceuticals (NASDAQ: ONXX) from “buy” to “hold.” The target price for ONYX Pharmaceuticals has been raised from $104 to $132. ONYX's shares closed at $134.40 yesterday.
Benchmark downgraded Guidance Software (NASDAQ: GUID) from “buy” to “sell.” The target price for Guidance Software has been lowered from $9 to $7. Guidance Software's shares closed at $9.53 yesterday.
Bank of America downgraded ViroPharma (NASDAQ: VPHM) from “buy” to “neutral.” The target price for ViroPharma is set to $34. ViroPharma's shares closed at $32.00 yesterday.
Analysts at Wunderlich downgraded United Stationers (NASDAQ: USTR) from “buy” to “hold.” The target price for United Stationers has been raised from $39 to $42. United Stationers' shares closed at $42.72 yesterday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.